Health-related quality of life in ALS, myasthenia gravis and facioscapulohumeral muscular dystrophy

[1]  K. Bötzel,et al.  Social and clinical determinants of quality of life in Parkinson's disease in a Russian cohort study. , 2010, Parkinsonism & related disorders.

[2]  K. Bötzel,et al.  Social and clinical determinants of quality of life in Parkinson’s disease in Austria: a cohort study , 2010, Journal of Neurology.

[3]  M. Leonardi,et al.  Concordance between severity of disease, disability and health-related quality of life in Myasthenia gravis , 2010, Neurological Sciences.

[4]  L. Padua,et al.  Quality of life and pain in patients with facioscapulohumeral muscular dystrophy , 2009, Muscle & nerve.

[5]  R. Barker,et al.  Health‐related quality of life in Huntington's disease: Which factors matter most? , 2009, Movement disorders : official journal of the Movement Disorder Society.

[6]  C. Jenkinson,et al.  Quality of life in amyotrophic lateral sclerosis/motor neuron disease: A structured review , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[7]  Robert H. Paul,et al.  Disease‐specific measure of quality of life for myasthenia gravis , 2008, Muscle & nerve.

[8]  A. Spottke,et al.  Health-related quality of life in patients with narcolepsy. , 2007, Sleep medicine.

[9]  G. Bleijenberg,et al.  Effects of training and albuterol on pain and fatigue in facioscapulohumeral muscular dystrophy , 2007, Journal of Neurology.

[10]  R. Dodel,et al.  Assessing health-related quality of life in patients with Parkinson's disease in a prospective longitudinal study. , 2007, Parkinsonism & related disorders.

[11]  J. Wokke Fatigue is part of the burden of neuromuscular diseases , 2007, Journal of Neurology.

[12]  L. H. van den Berg,et al.  Cross‐sectional and longitudinal correlations between disease progression and different health‐related quality of life domains in persons with amyotrophic lateral sclerosis , 2007, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[13]  S. Segerstrom,et al.  Psychological health in patients with amyotrophic lateral sclerosis , 2007, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[14]  L. Perestelo-Pérez,et al.  Social-economic costs and quality of life of Alzheimer disease in the Canary Islands, Spain , 2006, Neurology.

[15]  E. Stålberg,et al.  Correlation between regional myasthenic weakness and mental aspects of quality of life , 2006, European journal of neurology.

[16]  L. H. van den Berg,et al.  Multidisciplinary ALS care improves quality of life in patients with ALS , 2005, Neurology.

[17]  M. Zwarts,et al.  Experienced fatigue in facioscapulohumeral dystrophy, myotonic dystrophy, and HMSN-I , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[18]  R. Abresch,et al.  Chronic pain in persons with neuromuscular disease. , 2005, Archives of physical medicine and rehabilitation.

[19]  R. Pandey,et al.  Quality of life in patients with Parkinson's disease. , 2005, Parkinsonism & related disorders.

[20]  W. Greiner,et al.  Validating the EQ-5D with time trade off for the German population , 2005, The European Journal of Health Economics.

[21]  H. König,et al.  Gesundheitszustand der deutschen Bevölkerung: Ergebnisse einer repräsentativen Befragung mit dem EuroQol-Instrument , 2005 .

[22]  A. Chiò,et al.  A cross sectional study on determinants of quality of life in ALS , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[23]  R. Fitzpatrick,et al.  Health-Related Quality of Life in Amyotrophic Lateral Sclerosis: Determining a Meaningful Deterioration , 2004, Quality of Life Research.

[24]  N. Barbaro,et al.  Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease. , 2003, Archives of neurology.

[25]  M. Swash,et al.  Factors which predict physical and mental health status in patients with amyotrophic lateral sclerosis over time , 2003 .

[26]  T D Koepsell,et al.  Prognosis in amyotrophic lateral sclerosis , 2003, Neurology.

[27]  R. Abresch,et al.  Assessment of pain and health-related quality of life in slowly progressive neuromuscular disease , 2002, The American journal of hospice & palliative care.

[28]  P. Leigh,et al.  Patients' health-related quality of life and utilities associated with different stages of amyotrophic lateral sclerosis , 2001, Journal of the Neurological Sciences.

[29]  P. Tonali,et al.  Health-related quality of life in patients with myasthenia gravis and the relationship between patient-oriented assessment and conventional measurements , 2001, Neurological Sciences.

[30]  F. Pauri,et al.  Health-related quality of life in type 1 diabetic patients and influence of peripheral nerve involvement , 2001, Neurological Sciences.

[31]  R. Paul,et al.  What have we learned about cognition in myasthenia gravis?: a review of methods and results , 2001, Neuroscience & Biobehavioral Reviews.

[32]  Frank E. Harrell,et al.  Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis , 2001 .

[33]  M. Swash,et al.  The ALS Health Profile Study: quality of life of amyotrophic lateral sclerosis patients and carers in Europe , 2000, Journal of Neurology.

[34]  Marjan Jahanshahi,et al.  What contributes to quality of life in patients with Parkinson's disease? , 2000, Journal of neurology, neurosurgery, and psychiatry.

[35]  A N N Gardulf,et al.  The health-related quality of life of patients suffering from the late effects of polio (post-polio). , 2000, Journal of advanced nursing.

[36]  R. Barohn,et al.  Myasthenia gravis , 2000, Neurology.

[37]  D B Sanders,et al.  Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. , 2000, Neurology.

[38]  U. Ellert,et al.  [The SF-36 in the Federal Health Survey--description of a current normal sample]. , 1999, Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)).

[39]  J. Mendell,et al.  Definitive molecular diagnosis of facioscapulohumeral dystrophy , 1999, Neurology.

[40]  B. Brooks,et al.  El escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis , 1994, Journal of the Neurological Sciences.

[41]  N. Jones,et al.  Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire , 1993, Quality of Life Research.

[42]  S. Folstein,et al.  “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .

[43]  C. Swinyard,et al.  Gradients of functional ability of importance in rehabilitation of patients with progressive muscular and neuromuscular diseases. , 1957, Archives of physical medicine and rehabilitation.

[44]  W. Oertel,et al.  Socioeconomic burden of amyotrophic lateral sclerosis, myasthenia gravis and facioscapulohumeral muscular dystrophy , 2009, Journal of Neurology.

[45]  B. Giraudeau,et al.  Quality of life in ALS is maintained as physical function declines , 2001, Neurology.

[46]  Thomas L. Schwenk,et al.  Physical Activity and Mental Health , 2000, Sports medicine.

[47]  Monika Bullinger,et al.  SF-36, Fragebogen zum Gesundheitszustand , 1998 .

[48]  K. Yorkston,et al.  Amyotrophic lateral sclerosis severity scale. , 1989, Neuroepidemiology.

[49]  Mulder Dw Clinical limits of amyotrophic lateral sclerosis. , 1982 .